Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Conrad Housand

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Toxicology and Applied Pharmacology|October 22, 2023
Towards translating in vitro measures of thyroid hormone system disruption to in vivo responses in the pregnant rat via a biologically based dose response (BBDR) modelJeffrey Fisher, Conrad Housand, David Mattie, et al.
Journal of Clinical Pharmacology|July 30, 2021
Brexpiprazole Pharmacokinetics in CYP2D6 Poor Metabolizers: Using Physiologically Based Pharmacokinetic Modeling to Optimize Time to Effective ConcentrationsAhmed Elmokadem, Christopher D Bruno, Conrad Housand, et al.
Journal of Clinical Pharmacology|August 2, 2021
Impact of Obesity on Brexpiprazole Pharmacokinetics: Proposal for Improved Initiation of TreatmentChristopher D Bruno, Ahmed Elmokadem, Conrad Housand, et al.
Current Opinion in Toxicology|January 9, 2018
Quantitative systems toxicologyPeter Bloomingdale, Conrad Housand, Joshua F Apgar, et al.
International Journal of Environmental Research and Public Health|December 9, 2020
How Many Urine Samples Are Needed to Accurately Assess Exposure to Non-Persistent Chemicals? The Biomarker Reliability Assessment Tool (BRAT) for Scientists, Research Sponsors, and Risk ManagersMarc-André Verner, Hassan Salame, Conrad Housand, et al.
Chemosphere|October 2, 2013
Lifetime PCB 153 bioaccumulation and pharmacokinetics in pilot whales: Bayesian population PBPK modeling and Markov chain Monte Carlo simulationsLiesbeth Weijs, Anthony C Roach, Raymond S H Yang, et al.
Environmental Research|December 23, 2019
Quantitative bias analysis of the association between subclinical thyroid disease and two perfluoroalkyl substances in a single studyMichael W Dzierlenga, Marjory Moreau, Gina Song, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Toxicology and Applied Pharmacology|October 22, 2023
Towards translating in vitro measures of thyroid hormone system disruption to in vivo responses in the pregnant rat via a biologically based dose response (BBDR) modelJeffrey Fisher, Conrad Housand, David Mattie, et al.
Journal of Clinical Pharmacology|July 30, 2021
Brexpiprazole Pharmacokinetics in CYP2D6 Poor Metabolizers: Using Physiologically Based Pharmacokinetic Modeling to Optimize Time to Effective ConcentrationsAhmed Elmokadem, Christopher D Bruno, Conrad Housand, et al.
Journal of Clinical Pharmacology|August 2, 2021
Impact of Obesity on Brexpiprazole Pharmacokinetics: Proposal for Improved Initiation of TreatmentChristopher D Bruno, Ahmed Elmokadem, Conrad Housand, et al.
Current Opinion in Toxicology|January 9, 2018
Quantitative systems toxicologyPeter Bloomingdale, Conrad Housand, Joshua F Apgar, et al.
International Journal of Environmental Research and Public Health|December 9, 2020
How Many Urine Samples Are Needed to Accurately Assess Exposure to Non-Persistent Chemicals? The Biomarker Reliability Assessment Tool (BRAT) for Scientists, Research Sponsors, and Risk ManagersMarc-André Verner, Hassan Salame, Conrad Housand, et al.
Chemosphere|October 2, 2013
Lifetime PCB 153 bioaccumulation and pharmacokinetics in pilot whales: Bayesian population PBPK modeling and Markov chain Monte Carlo simulationsLiesbeth Weijs, Anthony C Roach, Raymond S H Yang, et al.
Environmental Research|December 23, 2019
Quantitative bias analysis of the association between subclinical thyroid disease and two perfluoroalkyl substances in a single studyMichael W Dzierlenga, Marjory Moreau, Gina Song, et al.
Pageof 1